Abstract
The use of the adrenomedullary tracer metaiodobenzylguanidine (MIBG) in the localization of medullary carcinoma of the thyroid (MCT) is based on the embryologic relationship of the APUD cell series. The authors report the results obtained in six patients with MCT: two had Sipple's syndrome and four sporadic forms of the disease. MIBG uptake by the CMT was observed in both cases of Sipple's syndrome and in only one of the other cases. Scintigraphic detection seems to depend on the clinical features, the size of the tumour and also on the part played by its secretory function. MCT would thus appear to be more frequently visualized by MIBG in cases of Sipple's syndrome than in sporadic cases. The procedure therefore seems useful in the diagnosis, follow up and even in the treatment of MCT.
Similar content being viewed by others
References
Baulieu JL, Guilloteau D, Calmettes C, Coutris G, Delisle MJ, Gardet P, Baulieu F, Delepine N, Itti R, Pourcelot L, Besnard JL, the French Medullary Cancer Study Group (1986) MIBG uptake in medullary thyroid cancer (MTC): a feature of multiple endocrine neoplasia (MEN) J Nucl Med 27:1009 (abstr.)
Coutris G, Talbot JN, Kabla G, Calmettes C, Milhaud G (1986) Uptake of 131I-MIBG by medullary carcinoma of the thyroid in familial cases. Eur J Nucl Med 12:77–79
Endo K, Shiomi K, Kasagi K, Konishi J, Torizuka K, Nakao K, Tanimura H (1984) Imaging of medullary thyroid cancer with 131I-MIBG. Lancet II:233–234
Gétin F, Rohmer V, Saint-André JP, Jallet P, Bigorgne JC (1985) Localisation du cancer médullaire de la thyroïde par la scintigraphie à la méta-iodo-benzylguanidine. Presse Med 14:597
Guilloteau D, Baulieu JL, Besnard JC (1985) Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F (ab′)2 and méta-iodo-benzyl-guanidine. Eur J Nucl Med 11:198–200
Hazard JB, Hawk WA, Crile G (1959) Medullary (solid) carcinoma of the thyroid: A clinico-pathologic entity. J Clin Endocrinol Metab 19:152–161
Hilditch TE, Connell JM, Elliot AT, Murray T, Reed NS (1986) Poor results with technetium-99m (V) DMSA and iodine 131 MIBG in the imaging of thyroid carcinoma. J Nucl Med 26:1150–1153
Hill CS Jr, Ibanez ML, Samaan NA, Ahearn MJ, Clark RL (1973) Medullary (solid) carcinoma of the thyroid gland: An analysis of the M.D. Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis. Medicine 52:141
Khairi MRA, Dexter RN, Burzynski NJ, Johnston CC, Jr (1975) Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: Multiple endocrine neoplasia, type III. Medicine 54:89
Nakajo M, Shapiro B, Kalff V, Gross MD, Sisson JC, Beierwaltes WH (1983) The normal and abnormal distribution of the adrenomedullary imaging agent m-(I-131) Iodobenzyl guanidine (I-131 MIBG) in man: Evaluation by scintigraphy. J Nucl Med 24:672–682
Pearse AGE (1969) The cytochemistry and ultrastructure of polypeptide human producing cells of the APUD series and the embryologie implication of the concept. J Histochem Cytochem 17:303–313
Poston GJ, Thomas AM, MacDonald DW, Lynn JA, Lavender JP (1985) 131I-MIBG uptake by medullary carcinoma of the thyroid. Lancet II:560
Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:1111–1118
Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwaltes WH, Thompson NW (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305:12–17
Steiner AL, Goodman AD, Powers SR (1968) Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia type II. Medicine 47:371
Teruki S, Masao F, Nobuaki O, Rikuski M, Akiru M, Shinichi Y, Tasushi T, Hiroki N, Tanekazu H (1985) Metastatic medullary thyroid cancer: Localization with Iodine-131 metaiodobenzylguanidine. J Nucl Med 26:604–608
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perdrisot, R., Rohmer, V., Lejeune, J.J. et al. Thyroid uptake of MIBG in Sipple's syndrome. Eur J Nucl Med 14, 37–38 (1988). https://doi.org/10.1007/BF00252616
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00252616